Parkinson's Disease (PD) is a progressive neurodegenerative disorder that significantly impacts both motor and non-motor functions, including speech. Early and accurate recognition of PD through speech analysis can greatly enhance patient outcomes by enabling timely intervention. This paper provides a comprehensive review of methods for PD recognition using speech data, highlighting advances in machine learning and data-driven approaches. We discuss the process of data wrangling, including data collection, cleaning, transformation, and exploratory data analysis, to prepare the dataset for machine learning applications. Various classification algorithms are explored, including logistic regression, SVM, and neural networks, with and without feature selection. Each method is evaluated based on accuracy, precision, and training time. Our findings indicate that specific acoustic features and advanced machine-learning techniques can effectively differentiate between individuals with PD and healthy controls. The study concludes with a comparison of the different models, identifying the most effective approaches for PD recognition, and suggesting potential directions for future research.

Parkinson's disease (PD) is a debilitating neurological disorder that necessitates precise and early diagnosis for effective patient care. This study aims to develop a diagnostic model capable of achieving both high accuracy and minimizing false negatives, a critical factor in clinical practice. Given the limited training data, a feature selection strategy utilizing ANOVA is employed to identify the most informative features. Subsequently, various machine learning methods, including Echo State Networks (ESN), Random Forest, k-nearest Neighbors, Support Vector Classifier, Extreme Gradient Boosting, and Decision Tree, are employed and thoroughly evaluated. The statistical analyses of the results highlight ESN's exceptional performance, showcasing not only superior accuracy but also the lowest false negative rate among all methods. Consistently, statistical data indicates that the ESN method consistently maintains a false negative rate of less than 8% in 83% of cases. ESN's capacity to strike a delicate balance between diagnostic precision and minimizing misclassifications positions it as an exemplary choice for PD diagnosis, especially in scenarios characterized by limited data. This research marks a significant step towards more efficient and reliable PD diagnosis, with potential implications for enhanced patient outcomes and healthcare dynamics.